Menicon Co., Ltd.

Equities

7780

JP3921270009

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-07-05 am EDT			5-day change	1st Jan Change
1,299 ^JPY	-1.85%		-1.67%	-44.70%

Jun. 27	Menicon Grants 330 Units of Share Remuneration-Type Stock Options	MT
May. 30	Menicon Reintroduces Employee Stock Ownership Plan	MT

Menicon Co., Ltd. acquired Laboratoires Dencott.

April 03, 2024

Menicon Co., Ltd. (TSE:7780) acquired Laboratoires Dencott on March 22, 2024. PwC Société d'Avocats acted as legal advisor to Menicon Co., Ltd.

Menicon Co., Ltd. (TSE:7780) completed the acquisition of Laboratoires Dencott on March 22, 2024.

Latest news about Menicon Co., Ltd.

Menicon Grants 330 Units of Share Remuneration-Type Stock Options	Jun. 26	MT
Menicon Reintroduces Employee Stock Ownership Plan	May. 29	MT
Menicon Establishes German Subsidiary and Alters Capital Increase Payment Timing	Apr. 05	MT
Menicon Buys French Specialty Contact Lens Maker Dencott	Apr. 04	MT
Menicon Co., Ltd. acquired Laboratoires Dencott.	Apr. 03	CI
Menicon Boosts Capital of Germany Unit Menicon SC, Making it Specified Subsidiary	Mar. 26	MT
Menicon Acquires New Site for Manufacturing Hub	Mar. 12	MT
Menicon Co., Ltd. Announces Acquisition of Fukui New Site in Hokuriku Area to Manufacture and Production of Contact Lenses and Lens Care Products	Mar. 10	CI
Tohoku University, The University of Tokyo, and Menicon Co., Ltd. to Start Joint Research on Fundamental Technology for Contact Lenses	Feb. 29	CI
Menicon Co., Ltd. and Tohoku University Establish the Menicon × Tohoku University Co-Creation Research Center	Feb. 29	CI
Menicon Co., Ltd. Announces CFO Changes, Effective from April 1, 2024	Feb. 28	CI
Menicon Co., Ltd. Announces Executive Changes	Feb. 28	CI
Menicon Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Feb. 13	CI
Menicon Co., Ltd. Announces the Launch of "1MONTH Menicon MelsME" and "1MONTH MeniconMelsME Toric	Nov. 30	CI
Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Nov. 13	CI
Menicon Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 13	CI
Menicon Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-08-10	CI
Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-08-10	CI
Menicon Co., Ltd. Launches the Soft Contact Lens Cleaning and Disinfecting Solution	23-05-31	CI
Menicon Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15	CI
Menicon Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-05-15	CI
Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-05-15	CI
Menicon Co., Ltd. Declares A Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 26, 2023	23-05-15	CI
Menicon Co., Ltd. Announces Launch of Orthokeratology Lens “Menicon Z Night”	23-05-15	CI
Menicon Announces Succession of President	23-02-23	MT

Chart Menicon Co., Ltd.

Duration

Period

More charts

Company Profile

Menicon Co., Ltd. is a Japan-based company mainly engaged in operation of contact lens related business and other business. The Company has two business segments. With its subsidiaries, the Contact Lens segment is engaged in manufacture and sales of contact lens, care supplies and other goods. The Others segment is engaged in development and sales of veterinary medical products, decomposition accelerator of rice straw, composting accelerator of livestock excrement, assisted reproductive medicine and products of advanced medical fields, as well as management of contact lens retailer staff training school and provision of temporary staffing service, among others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-08 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Menicon Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,299 JPY

Average target price

2,554 JPY

Spread / Average Target

+96.61%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
MENICON CO., LTD.	-44.70%	616M
ALCON INC.	+21.91%	44.08B
THE COOPER COMPANIES, INC.	-9.21%	17.1B
AUTEK CHINA INC.	-31.67%	1.9B
WARBY PARKER INC.	+11.49%	1.87B
PEGAVISION CORPORATION	+8.70%	1.04B
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-8.84%	659M
SHANGHAI CONANT OPTICAL CO., LTD.	+64.31%	633M
MINGYUE OPTICAL LENS CO.,LTD.	-45.94%	625M
VISCO VISION INC.	+33.87%	564M

Glasses, Spectacles & Contact Lenses